NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors : A Retrospective Molecular Tumor Board Analysis

Identifying the mutational landscape of tumors using next-generation sequencing (NGS) has become substantially more common over the past decade, especially in patients with advanced tumors. However, there is still limited real-world evidence for the clinical benefits of NGS-guided precision oncol...

Full description

Saved in:
Bibliographic Details
Main Authors: Gremke, Niklas, Rodepeter, Fiona R., Teply-Szymanski, Julia, Griewing, Sebastian, Boekhoff, Jelena, Stroh, Alina, Tarawneh, Thomas S., Riera-Knorrenschild, Jorge, Balser, Christina, Hattesohl, Akira, Middeke, Martin, Ross, Petra, Litmeyer, Anne-Sophie, Romey, Marcel, Stiewe, Thorsten, Wündisch, Thomas, Neubauer, Andreas, Denkert, Carsten, Wagner, Uwe, Mack, Elisabeth K. M.
Format: Article
Language:English
Published: Philipps-Universität Marburg 2024
Subjects:
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

PDF Full Text

Holdings details from
Call Number: urn:nbn:de:hebis:04-es2024-09403
Publication Date: 2024-12-02
Source: Erstveröffentlichung: Gremke, N.; Rodepeter, F.R.; Teply-Szymanski, J.; Griewing, S.; Boekhoff, J.; Stroh, A.; Tarawneh, T.S.; Riera-Knorrenschild, J.; Balser, C.; Hattesohl, A.; et al. NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis. Cancers 2024, 16, 1561. https://doi.org/10.3390/cancers16081561
Downloads: 19 (2025), 4 (2024)
License: https://creativecommons.org/licenses/by/4.0
Access URL: https://archiv.ub.uni-marburg.de/es/2024/0940
https://doi.org/10.3390/cancers16081561